Selective targeting of alpha7 nicotinic acetylcholine receptor by synthetic peptide mimicking loop I of human SLURP-1 provides efficient and prolonged therapy of epidermoid carcinoma in vivo.
Shlepova OV, Shulepko MA, Shipunova VO, Bychkov ML, Kukushkin ID, Chulina IA, Azev VN, Shramova EI, Kazakov VA, Ismailova AM, Palikova YA, Palikov VA, Kalabina EA, Shaykhutdinova EA, Slashcheva GA, Tukhovskaya EA, Dyachenko IA, Murashev AN, Deyev SM, Kirpichnikov MP, Shenkarev ZO, Lyukmanova EN.
Shlepova OV, et al.
Front Cell Dev Biol. 2023 Oct 3;11:1256716. doi: 10.3389/fcell.2023.1256716. eCollection 2023.
Front Cell Dev Biol. 2023.
PMID: 37854069
Free PMC article.
alpha7-Type nicotinic acetylcholine receptor (alpha7-nAChR) promotes the growth and metastasis of solid tumors. ...Here, we investigated mechanisms of antiproliferative activity of recombinant SLURP-1 in epidermoid carcinoma A431 cells and activity of SLURP-1 …
alpha7-Type nicotinic acetylcholine receptor (alpha7-nAChR) promotes the growth and metastasis of solid tumors. ...Here, we investiga …